熱門資訊> 正文
bioAffinity将实施1比30反向股票分割
2025-09-17 20:32
- bioAffinity Technologies (NASDAQ:BIAF) plans to execute a 1-for-30 reverse split of its common stock to bring itself into compliance with Nasdaq’s minimum bid price requirement.
- Commencing with the opening of trading on the Nasdaq Capital Market on Sept. 19, 2025, the company’s common stock will trade on a post-split basis under the symbol BIAF.
- BIAF --16.7% premarket to $0.2174
- Source: Press Release
More on bioAffinity Technologies
- bioAffinity Technologies announces pricing of private placement
- Seeking Alpha’s Quant Rating on bioAffinity Technologies
- Historical earnings data for bioAffinity Technologies
- Financial information for bioAffinity Technologies
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。